MIRA
INFORM REPORT
|
Report Date : |
07.11.2007 |
IDENTIFICATION
DETAILS
|
Name : |
KAMPALA PHARMACEUTICALS LTD |
|
|
|
|
Registered Office : |
P. O Box 7551, Kampala |
|
|
|
|
Country : |
Uganda |
|
|
|
|
Date of Incorporation : |
25/11/1996 |
|
|
|
|
Com. Reg. No.: |
11456 |
|
|
|
|
Legal Form : |
Limited Liability Company, Limited by
shares |
|
|
|
|
Line of Business : |
Manufacturers & Retailers of
pharmaceuticals, drugs, and medicines |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 80,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
COMPANY REPORTED
KAMPALA PHARMACEUTICALS LTD
Principal Address
P.o Box 7551,
Kampala, Uganda
Telephone: +256-41-222721/ 285645
Fax: +256-41-220129
Email: mail@kpi.co.ug
Internet: www.kpi.co.ug
Established
25/11/1996
Registration
No. 11456 Kampala, Uganda
Legal Form
limited Liability company, Limited by shares
Stock Listing
Not Listed
Workforce
2006
240
Office & Factories
Head offices Plot No. M444/B, Stretcher Road, Ntinda, Ind. Area, Kampala, Uganda
Branches None
Company Profile
Paid in Capital UGX.
3,000,000,000
Subscribed Capital UGX.
2,781,000,000
Shareholders
Name Position Amount
Ratio
Mr. Zaherally Kassamally Ahmed CEO 1 0.00%
Kopran Ltd India Holding Co. 139,050 50.00%
Industrial Promotion Services(U) 1995 Ltd Shareholder 69,525 25.00%
Industrial Promotion Services (Kenya) Ltd Shareholder 41,714 15.00%
Jubilee investments co. Ltd, Uganda Shareholder 27,810 10.00%
Total
278,100 100.00%
Credit Opinion
Our proposed
credit amount of USD 80,000 is recommendable
Affiliated Companies
None
Management/ Directors
|
President/ CEO
(1) |
|
|
Name |
Mr. Zaherally
Kassamally Ahmed |
|
Remarks |
Top Decision Maker |
Þ Top decision maker is the person who has the ultimate authority or power to make important managerial decisions. He/She may or may not be officially registered as a president or an executive director.
Business Activities
Manufacturers & Retailers of pharmaceuticals,
drugs, and medicines
Terms of payment
Buying terms 30% in cash, 70% on credit
Selling terms 80% in cash, 20% on credit
Suppliers
Various
Customers
Hospitals, pharmacies etc
Recent Sales
UGX.1 2,000,000,000 (2006)
Exports
None
Export Ratio 0.0%
Import Ratio 20.0%
Domestic Market Share 35.0%
Banking relationship
Main Banks Diamond Trust Bank
Barclays Bank
Credit Check of Subject,
President & CEO (as of report date)
Payment Morale : In the documents at our disposal nothing adverse has been shown so far.
CREDIT RATING : Financial situation is average.
COMMENTS
Maximum credit we
recommend is USD 80,000 outstanding at any one time.
|
BALANCE SHEET ITEMS |
(In 000 UGX.) |
|
Fixed Assets |
6,500,000 |
|
Investments |
2,300,000 |
|
Accounts Receivable - Trade |
4,200,000 |
|
Accounts Payable - Trade |
3,000,000 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)